Newsbenzinga
What’s Going On With Tempus AI Stock on Monday?
· Published
Article summary
Tempus AI stock pulls back after a 20% surge as cancer data spotlights its Personalis deal, and FDA clears its pulmonary hypertension AI tool.
An excerpt from the original article.
Comments —
Loading comments…